Archives
Rahul Gupta to Be Nominated as Next U.S. Drug Czar
Gupta was the former health commissioner of West Virginia and is chief medical and health officer for the March of Dimes
WHO: Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots
Advocacy group ONE Campaign says only 1 percent of people in poor countries have received even one COVID-19 vaccine dose
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
Pfizer Presses U.S. Scientists, Officials on Third Booster Shot
U.S. officials say that more data are needed before regulators can determine whether booster shots are necessary
Lawsuits Claim Pesticide Caused Harm to Children’s Brains
Chlorpyrifos is approved for use on more than 80 crops but was banned for household use in 2001
WHO Calls for Global Registry of Human Genome Editing
Studies involving human genome editing should be made public, even though it would not necessarily stop unprincipled scientists
FDA Head Asks for Investigation Into Alzheimer Disease Drug Approval
Request follows reports that Biogen and the FDA held off-the-books meetings before the drug's approval that may have violated FDA protocol
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
Pfizer cited data from Israel showing the vaccine is declining in effectiveness as the highly contagious Delta variant circulates
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
ASCO Updates Recommendations for Managing Hereditary Breast Cancer
Rapid recommendation provides updated guidance on the use of adjuvant olaparib